cilostazol
- Product NDC
- 71610-813
- 11-digit product format
- 716100813
- Labeler code
- 71610
- Product ID
- 71610-813_1547a408-12a9-fadd-e063-6394a90a4ce0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077030
- Marketing category
- ANDA
- Marketing start
- 2022-04-12
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- cilostazol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CILOSTAZOL | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7Z035406B |
| Rxcui | 242461 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-813-26 | cilostazol | 1200 in 1 BOTTLE | TABLET | 1200 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-813 | CILOSTAZOL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC ] | 1 | Current NDC, 1 package rows | 20240407_15478d90-312f-014e-e063-6294a90ae838.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-813-26 | 71610081326 | 1200 TABLET in 1 BOTTLE (71610-813-26) | 1200 tablet | 2024-04-03 | No | No | Historical |